These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15955801)
1. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. Hamerman D QJM; 2005 Jul; 98(7):467-84. PubMed ID: 15955801 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates, statins, osteoporosis, and atherosclerosis. Watts N South Med J; 2002 Jun; 95(6):578-82. PubMed ID: 12081213 [No Abstract] [Full Text] [Related]
4. [Anabolic effects of statin and beta-blocker on bone metabolism]. Taguchi M; Takeuchi Y Clin Calcium; 2004 Dec; 14(12):89-94. PubMed ID: 15577180 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease and osteoporosis. Baldini V; Mastropasqua M; Francucci CM; D'Erasmo E J Endocrinol Invest; 2005; 28(10 Suppl):69-72. PubMed ID: 16550727 [TBL] [Abstract][Full Text] [Related]
7. [Coronary heart disease and osteoporosis: factors related to development of both diseases]. Nowicka G; Panczenko-Kresowska B Przegl Lek; 2007; 64(3):153-8. PubMed ID: 17941467 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease and osteoporosis: is there a link between lipids and bone? Burnett JR; Vasikaran SD Ann Clin Biochem; 2002 May; 39(Pt 3):203-10. PubMed ID: 12038594 [TBL] [Abstract][Full Text] [Related]
9. Role of statins in aortic valve disease. Rajamannan NM Heart Fail Clin; 2006 Oct; 2(4):395-413. PubMed ID: 17448427 [No Abstract] [Full Text] [Related]
10. Statins and bone metabolism. Horiuchi N; Maeda T Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028 [TBL] [Abstract][Full Text] [Related]
11. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo. Hughes A; Rogers MJ; Idris AI; Crockett JC Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704 [TBL] [Abstract][Full Text] [Related]
12. [Statins as possible therapeutic tools for osteoporosis]. Takeuchi Y; Takeda S Clin Calcium; 2004 Feb; 14(2):302-7. PubMed ID: 15576989 [TBL] [Abstract][Full Text] [Related]
13. Statins and osteoporosis: new role for old drugs. Jadhav SB; Jain GK J Pharm Pharmacol; 2006 Jan; 58(1):3-18. PubMed ID: 16393459 [TBL] [Abstract][Full Text] [Related]
15. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis]. Fukunaga M Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266 [TBL] [Abstract][Full Text] [Related]
16. [Statins and osteoporosis]. Svejda P Vnitr Lek; 2006 Dec; 52(12):1190-3. PubMed ID: 17299913 [TBL] [Abstract][Full Text] [Related]
17. PPAR gamma: ally and foe in bone metabolism. Wahli W Cell Metab; 2008 Mar; 7(3):188-90. PubMed ID: 18316021 [TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Toussaint ND; Elder GJ; Kerr PG Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295 [TBL] [Abstract][Full Text] [Related]